Asset Details
Do you wish to reserve the book?
Multiomics approach provides insight into altered choline metabolism and liver injury in patients with glycogen storage disease type Ia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Multiomics approach provides insight into altered choline metabolism and liver injury in patients with glycogen storage disease type Ia
Do you wish to request the book?
Multiomics approach provides insight into altered choline metabolism and liver injury in patients with glycogen storage disease type Ia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Multiomics approach provides insight into altered choline metabolism and liver injury in patients with glycogen storage disease type Ia
2025
Overview
Glycogen storage disease type Ia (GSDIa) is an inherited disorder of carbohydrate metabolism. Patients present with excessive storage of glycogen and fat in the liver and kidneys and are potentially at risk of developing long-term complications. Currently, the mainstay of treatment is highly tailored dietary regimens aimed at improving metabolic control. In the present study, to better elucidate the mechanisms potentially involved in the development of long-term complications, a mass spectrometry-based strategy was employed for an in-depth characterization of the serum proteomic and metabolomic profile of n.12 GSDIa patients. The detection of differential abundance of highly liver-specific circulating proteins and choline-related metabolites in patients provides new insights into the extent of liver damage and dysregulation of lipid metabolism in GSDIa. Specifically, the differential abundance of serum aldolase B and its positive correlation with traditional liver function markers supports its role as a potential biomarker for long-term monitoring of GSDIa liver injury.
Publisher
Nature Publishing Group UK,Nature Portfolio
Subject
/ Adult
/ ALDOB
/ Child
/ Female
/ Glycogen Storage Disease Type I - blood
/ Glycogen Storage Disease Type I - complications
/ Glycogen Storage Disease Type I - metabolism
/ Glycogen Storage Disease Type I - pathology
/ Glycogen storage disease type Ia
/ Humanities and Social Sciences
/ Humans
/ Male
/ Science
